Image pharmaphorum Editor Patients Leveraging real-world data to meet payers’ needs Payers are becoming savvier in accepting real-world data. Patients Time to take patient engagement to the next level Patient engagement in pharma is evolving, with some companies doing it better than others. Patients Patients want to be heard. Is pharma listening? A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Natalie Turner, director at AXON, a global healthcare communications agency. Patients Health literacy for the intellectually disabled: is pharma d... What is health literacy and why is it important? Load more results
Patients Leveraging real-world data to meet payers’ needs Payers are becoming savvier in accepting real-world data.
Patients Time to take patient engagement to the next level Patient engagement in pharma is evolving, with some companies doing it better than others.
Patients Patients want to be heard. Is pharma listening? A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Natalie Turner, director at AXON, a global healthcare communications agency.
Patients Health literacy for the intellectually disabled: is pharma d... What is health literacy and why is it important?
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
